NM_000098.3:c.416C>G
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2
The NM_000098.3(CPT2):c.416C>G(p.Pro139Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000616 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P139L) has been classified as Uncertain significance.
Frequency
Consequence
NM_000098.3 missense
Scores
Clinical Significance
Conservation
Publications
- carnitine palmitoyltransferase II deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
- carnitine palmitoyl transferase II deficiency, myopathic formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
- carnitine palmitoyl transferase II deficiency, neonatal formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
- carnitine palmitoyl transferase II deficiency, severe infantile formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet
- encephalopathy, acute, infection-induced, susceptibility to, 4Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPT2 | NM_000098.3 | MANE Select | c.416C>G | p.Pro139Arg | missense | Exon 4 of 5 | NP_000089.1 | ||
| CPT2 | NM_001330589.2 | c.416C>G | p.Pro139Arg | missense | Exon 4 of 5 | NP_001317518.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPT2 | ENST00000371486.4 | TSL:1 MANE Select | c.416C>G | p.Pro139Arg | missense | Exon 4 of 5 | ENSP00000360541.3 | ||
| CPT2 | ENST00000637252.1 | TSL:5 | c.416C>G | p.Pro139Arg | missense | Exon 4 of 6 | ENSP00000490492.1 | ||
| CPT2 | ENST00000635862.1 | TSL:5 | c.416C>G | p.Pro139Arg | missense | Exon 4 of 6 | ENSP00000490867.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251482 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Carnitine palmitoyl transferase II deficiency, neonatal form Uncertain:1
Carnitine palmitoyl transferase II deficiency, myopathic form;C1833511:Carnitine palmitoyl transferase II deficiency, severe infantile form;C1833518:Carnitine palmitoyl transferase II deficiency, neonatal form;C3280160:Encephalopathy, acute, infection-induced, susceptibility to, 4 Uncertain:1
Carnitine palmitoyl transferase II deficiency, myopathic form Uncertain:1
Encephalopathy, acute, infection-induced, susceptibility to, 4 Uncertain:1
Carnitine palmitoyl transferase II deficiency, severe infantile form Uncertain:1
Carnitine palmitoyltransferase II deficiency Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 139 of the CPT2 protein (p.Pro139Arg). This variant is present in population databases (rs369475478, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CPT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 460435). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CPT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at